MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$1,254,078
EPS
-$0.28
Unit: Dollar

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
-86,727 129,390 211,140.5*
Research and development
720,973 791,581 993,475 1,050,810.5*
General and administrative
553,299 651,721 463,736 623,466*
Total costs and expenses
1,274,272 1,443,302 1,457,211 1,674,276.5*
Loss from operations
-1,274,272 -1,356,575 -1,327,821 -1,463,136*
Interest income, net
20,194 29,089 21,298 21,046.5
Total other income/(expense)
20,194 29,089 21,298 21,046.5*
Loss before income taxes
-1,254,078 -1,327,486 -1,306,523 -1,442,089.5
Provision for income taxes
-0 --
Net loss
-1,254,078 -1,327,486 -1,306,523 -1,442,089.5
Basic EPS
-0.28 -0.31 -0.64 -1.376
Diluted EPS
-0.28 -0.31 -0.64 -1.376
Basic Average Shares
4,549,120 4,305,243 2,056,804 1,048,185*
Diluted Average Shares
4,549,120 4,305,243 2,056,804 1,048,185*
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$1,254,078 (13.19%↑ Y/Y)Interest income, net$20,194 (36.65%↑ Y/Y)Loss before incometaxes-$1,254,078 (13.19%↑ Y/Y)Total otherincome/(expense)$20,194 (36.65%↑ Y/Y)Loss from operations-$1,274,272 (12.69%↑ Y/Y)Total costs andexpenses$1,274,272 (-17.24%↓ Y/Y)Research and development$720,973 (-31.12%↓ Y/Y)General andadministrative$553,299 (12.21%↑ Y/Y)

LIPELLA PHARMACEUTICALS INC. (LIPO)

LIPELLA PHARMACEUTICALS INC. (LIPO)